Trial Profile
Expanded Access Protocol Using HBOC-201 to Treat Patients With Life Threatening Anemia, for Whom Blood is Not an Option
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Sep 2020
Price :
$35
*
At a glance
- Drugs Hemoglobin glutamer (Primary)
- Indications Anaemia
- Focus Expanded access; Therapeutic Use
- 07 Jun 2016 Status changed from suspended to recruiting.
- 22 Feb 2016 New trial record